Anbio Biotechnology (NNNN) Total Current Liabilities (2023 - 2025)

Historic Total Current Liabilities for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $131.1 billion.

  • Anbio Biotechnology's Total Current Liabilities changed N/A to $131.1 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $131.1 billion, marking a year-over-year change of. This contributed to the annual value of $1730.2 billion for FY2024, which is 17423247406.4% up from last year.
  • Per Anbio Biotechnology's latest filing, its Total Current Liabilities stood at $131.1 billion for Q2 2025.
  • In the past 5 years, Anbio Biotechnology's Total Current Liabilities registered a high of $1730.2 billion during Q4 2024, and its lowest value of $993060.0 during Q4 2023.
  • In the last 3 years, Anbio Biotechnology's Total Current Liabilities had a median value of $131.1 billion in 2025 and averaged $620.5 billion.
  • Data for Anbio Biotechnology's Total Current Liabilities shows a peak YoY increase of 17423247406.4% (in 2024) and a maximum YoY decrease of 17423247406.4% (in 2024) over the last 5 years.
  • Over the past 3 years, Anbio Biotechnology's Total Current Liabilities (Quarter) stood at $993060.0 in 2023, then surged by 174232474.06% to $1730.2 billion in 2024, then plummeted by 92.42% to $131.1 billion in 2025.
  • Its last three reported values are $131.1 billion in Q2 2025, $1730.2 billion for Q4 2024, and $993060.0 during Q4 2023.